AptarGroup, Inc. (ATR) 10-Year Financial Performance & Capital Metrics

ATR • • Industrial / General

HealthcareMedical InstrumentsMedical Consumables & DisposablesMedical Packaging & Containers

AboutAptarGroup, Inc. provides a range of dispensing, sealing, and material science solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectable, and food and beverage markets. The company operates through three segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma segment provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases in pharmaceutical market; elastomer for injectable primary packaging components; and active material science solutions. The Beauty + Home segment primarily sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. The Food + Beverage segment offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. It sells its products through own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. The company has a strategic partnership with PureCycle Technologies LLC to develop ultra-pure recycled polypropylene into dispensing applications; and a collaboration with Sonmol for developing a digital therapies and services platform targeting respiratory and other diseases. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.Show more

Revenue $3.58B +2.7%
EBITDA $760M +16.5%
Net Income $375M +31.7%
EPS (Diluted) 5.53 +30.1%
Gross Margin 37.83% +4.4%
EBITDA Margin 21.22% +13.4%
Operating Margin 13.86% +19.6%
Net Margin 10.45% +28.1%
ROE 15.58% +20.2%
ROIC 11.25% +19.4%
Debt/Equity 0.43 -15.2%
Interest Coverage 11.31 +13.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Dividend Aristocrat: 32 years of consecutive increases
✓Strong Piotroski F-Score: 8/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y3.27%

5Y4.61%

3Y3.55%

TTM2.5%

Profit (Net Income) CAGR

10Y6.93%

5Y9.11%

3Y15.34%

TTM24.79%

EPS CAGR

10Y6.85%

5Y8.6%

3Y15.38%

TTM25.5%

ROCE

10Y Avg13.13%

5Y Avg12.28%

3Y Avg13.12%

Latest15.13%

Peer Comparison

Medical Packaging & Containers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
STVNStevanato Group S.p.A.	1.04B	21.00	48.84	1.72%	12.01%	9.78%		0.31
WSTWest Pharmaceutical Services, Inc.	20.1B	279.41	41.77	-1.98%	16.3%	16.11%	1.38%	0.11
ATRAptarGroup, Inc.	8.21B	125.11	22.62	2.74%	11.45%	14.91%	4.25%	0.43
MHUAMeihua International Medical Technologies Co., Ltd.	181.69M	3.25	0.08	-0.19%	10.09%	11.25%	7.98%	0.05

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	2.32B	2.33B	2.47B	2.76B	2.86B	2.93B	3.23B	3.32B	3.49B	3.58B
Revenue Growth %	-0.11%	0.01%	0.06%	0.12%	0.03%	0.02%	0.1%	0.03%	0.05%	0.03%
Cost of Goods Sold+	1.5B	1.5B	1.6B	1.81B	1.82B	1.84B	2.07B	2.16B	2.22B	2.23B
COGS % of Revenue	0.65%	0.64%	0.65%	0.66%	0.64%	0.63%	0.64%	0.65%	0.64%	0.62%
Gross Profit+	814.5M	832.86M	865.1M	951.8M	1.04B	1.09B	1.16B	1.16B	1.26B	1.36B
Gross Margin %	0.35%	0.36%	0.35%	0.34%	0.36%	0.37%	0.36%	0.35%	0.36%	0.38%
Gross Profit Growth %	-0.03%	0.02%	0.04%	0.1%	0.09%	0.04%	0.06%	0.01%	0.09%	0.07%
Operating Expenses+	490.35M	522.36M	541.38M	601.7M	649.17M	747.02M	809.34M	784.57M	859.38M	859.01M
OpEx % of Revenue	0.21%	0.22%	0.22%	0.22%	0.23%	0.26%	0.25%	0.24%	0.25%	0.24%
Selling, General & Admin	351.46M	367.56M	388.28M	429.95M	454.62M	500.23M	551.24M	544.26M	565.78M	582.23M
SG&A % of Revenue	0.15%	0.16%	0.16%	0.16%	0.16%	0.17%	0.17%	0.16%	0.16%	0.16%
Research & Development	67.1M	66.2M	68.2M	75.3M	82.8M	92.5M	99.8M	0	0	0
R&D % of Revenue	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	0.03%	-	-	-
Other Operating Expenses	163K	2.78M	8.66M	5.55M	111.75M	154.29M	158.29M	240.3M	293.6M	276.79M
Operating Income+	324.14M	310.5M	321.52M	286.27M	371.69M	339.5M	347.35M	379.27M	404.02M	496.5M
Operating Margin %	0.14%	0.13%	0.13%	0.1%	0.13%	0.12%	0.11%	0.11%	0.12%	0.14%
Operating Income Growth %	0.06%	-0.04%	0.04%	-0.11%	0.3%	-0.09%	0.02%	0.09%	0.07%	0.23%
EBITDA+	463.04M	465.3M	474.61M	458.02M	566.25M	559.8M	582.2M	612.98M	652.61M	760.28M
EBITDA Margin %	0.2%	0.2%	0.19%	0.17%	0.2%	0.19%	0.18%	0.18%	0.19%	0.21%
EBITDA Growth %	0.01%	0%	0.02%	-0.03%	0.24%	-0.01%	0.04%	0.05%	0.06%	0.16%
D&A (Non-Cash Add-back)	138.89M	154.8M	153.09M	171.75M	194.55M	220.3M	234.85M	233.71M	248.59M	263.78M
EBIT	329.19M	315.73M	335.42M	298.65M	377.56M	334.4M	351.94M	375.53M	415.24M	513.66M
Net Interest Income+	-29.02M	-32.59M	-35.13M	-25.57M	-31.32M	-32.29M	-26.62M	-38.13M	-36.05M	-31.8M
Interest Income	5.6M	2.64M	5.47M	7.06M	4.17M	958K	3.67M	2.7M	4.37M	12.1M
Interest Expense	34.62M	35.24M	40.6M	32.63M	35.49M	33.24M	30.28M	40.83M	40.42M	43.9M
Other Income/Expense	-29.57M	-35.6M	-28.66M	-20.25M	-29.62M	-38.34M	-25.69M	-44.57M	-29.19M	-26.73M
Pretax Income+	294.57M	280.5M	294.82M	266.02M	342.07M	301.15M	321.65M	334.7M	374.82M	469.76M
Pretax Margin %	0.13%	0.12%	0.12%	0.1%	0.12%	0.1%	0.1%	0.1%	0.11%	0.13%
Income Tax+	95.28M	74.89M	74.8M	71.25M	99.84M	87.06M	78.02M	95.15M	90.65M	95.59M
Effective Tax Rate %	0.68%	0.73%	0.75%	0.73%	0.71%	0.71%	0.76%	0.71%	0.76%	0.8%
Net Income+	199.35M	205.59M	220.03M	194.75M	242.2M	214.04M	244.1M	239.29M	284.49M	374.54M
Net Margin %	0.09%	0.09%	0.09%	0.07%	0.08%	0.07%	0.08%	0.07%	0.08%	0.1%
Net Income Growth %	0.04%	0.03%	0.07%	-0.11%	0.24%	-0.12%	0.14%	-0.02%	0.19%	0.32%
Net Income (Continuing)	199.29M	205.6M	220.03M	194.77M	242.23M	214.09M	243.64M	239.56M	284.18M	374.18M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	295K	292K	310K	315K	336K	396K	15.19M	14.27M	14.47M	14.04M
EPS (Diluted)+	3.09	3.17	3.41	3.00	3.66	3.21	3.60	3.59	4.25	5.53
EPS Growth %	0.08%	0.03%	0.08%	-0.12%	0.22%	-0.12%	0.12%	-0%	0.18%	0.3%
EPS (Basic)	3.19	3.27	3.52	3.12	3.81	3.32	3.72	3.66	4.34	5.65
Diluted Shares Outstanding	64.49M	64.85M	64.6M	64.96M	66.15M	66.66M	67.68M	66.72M	66.91M	67.69M
Basic Shares Outstanding	62.59M	62.8M	62.44M	62.44M	63.57M	64.42M	65.66M	65.4M	65.62M	66.33M
Dividend Payout Ratio	0.36%	0.37%	0.36%	0.42%	0.37%	0.43%	0.4%	0.42%	0.36%	0.3%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	1.29B	1.27B	1.67B	1.33B	1.29B	1.37B	1.36B	1.43B	1.55B	1.48B
Cash & Short-Term Investments	519.72M	466.29M	712.64M	261.82M	241.97M	300.38M	123.67M	141.73M	223.64M	226.18M
Cash Only	489.9M	466.29M	712.64M	261.82M	241.97M	300.14M	122.92M	141.73M	223.64M	223.84M
Short-Term Investments	29.82M	0	0	0	0	243K	740K	0	0	2.34M
Accounts Receivable	391.57M	433.13M	510.43M	569.63M	558.43M	566.62M	671.35M	676.99M	677.82M	658.06M
Days Sales Outstanding	61.68	67.82	75.45	75.2	71.27	70.6	75.93	74.38	70.94	67.04
Inventory	294.91M	296.91M	337.22M	381.11M	375.8M	379.38M	441.46M	486.81M	513.05M	461.81M
Days Inventory Outstanding	71.64	72.34	76.73	76.73	75.43	75.14	77.82	82.32	84.2	75.68
Other Current Assets	0	0	0	0	0	0	0	124.77M	134.76M	13.64M
Total Non-Current Assets+	1.14B	1.34B	1.47B	2.05B	2.27B	2.62B	2.78B	2.77B	2.9B	2.95B
Property, Plant & Equipment	765.38M	784.32M	867.91M	991.61M	1.16B	1.27B	1.34B	1.4B	1.54B	1.51B
Fixed Asset Turnover	3.03x	2.97x	2.85x	2.79x	2.47x	2.31x	2.41x	2.37x	2.27x	2.37x
Goodwill	310.24M	407.52M	443.89M	712.1M	763.46M	898.52M	974.16M	945.63M	963.42M	936.26M
Intangible Assets	31.53M	94.49M	95.46M	254.9M	291.08M	344.31M	362.34M	315.74M	283.21M	254.77M
Long-Term Investments	4.59M	4.24M	9.44M	25.45M	8.4M	50.09M	59.48M	52.31M	49.2M	146.27M
Other Non-Current Assets	30.31M	46.04M	51.05M	62.87M	47.88M	59.55M	48.84M	57.14M	69.64M	105.24M
Total Assets+	2.44B	2.61B	3.14B	3.38B	3.56B	3.99B	4.14B	4.2B	4.45B	4.43B
Asset Turnover	0.95x	0.89x	0.79x	0.82x	0.80x	0.73x	0.78x	0.79x	0.78x	0.81x
Asset Growth %	-0%	0.07%	0.2%	0.08%	0.05%	0.12%	0.04%	0.01%	0.06%	-0%
Total Current Liabilities+	411.89M	542.96M	527.75M	689.17M	683.27M	780.33M	982.49M	917.18M	1.25B	1.07B
Accounts Payable	115.06M	115.51M	153.86M	164.53M	192.74M	243.74M	285.26M	320.28M	328.57M	295.97M
Days Payables Outstanding	27.95	28.14	35.01	33.12	38.69	48.28	50.29	54.16	53.92	48.5
Short-Term Debt	56.97M	173.82M	66.17M	163.97M	110.25M	113.61M	285.88M	122.79M	458.22M	338.29M
Deferred Revenue (Current)	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Liabilities	125.2M	118.96M	143.57M	168.35M	163.84M	177.14M	195.31M	206.33M	222.01M	211.44M
Current Ratio	3.14x	2.34x	3.16x	1.93x	1.89x	1.75x	1.38x	1.56x	1.24x	1.38x
Quick Ratio	2.43x	1.79x	2.53x	1.38x	1.34x	1.27x	0.93x	1.03x	0.83x	0.95x
Cash Conversion Cycle	105.37	112.02	117.17	118.81	108.02	97.47	103.47	102.54	101.22	94.21
Total Non-Current Liabilities+	875.44M	889.59M	1.3B	1.27B	1.31B	1.36B	1.17B	1.22B	879.28M	878.07M
Long-Term Debt	760.85M	772.74M	1.19B	1.13B	1.09B	1.05B	907.02M	1.05B	681.19M	688.07M
Capital Lease Obligations	1.11M	739K	135K	0	55.28M	52.21M	48.01M	42.95M	45.27M	49.72M
Deferred Tax Liabilities	20.49M	16.8M	21M	53.92M	41.39M	37.24M	27.55M	20.56M	19.02M	14.26M
Other Non-Current Liabilities	93M	99.31M	85.75M	85.78M	124.47M	192.9M	169.79M	76.61M	96.06M	126.03M
Total Liabilities	1.29B	1.43B	1.83B	1.95B	1.99B	2.14B	2.16B	2.14B	2.13B	1.95B
Total Debt+	819.44M	948.1M	1.26B	1.29B	1.25B	1.23B	1.24B	1.22B	1.18B	1.08B
Net Debt	329.54M	481.81M	545.42M	1.03B	1.01B	924.94M	1.12B	1.08B	961.03M	852.22M
Debt / Equity	0.71x	0.81x	0.96x	0.91x	0.80x	0.66x	0.63x	0.59x	0.51x	0.43x
Debt / EBITDA	1.77x	2.04x	2.65x	2.82x	2.21x	2.19x	2.14x	1.99x	1.82x	1.42x
Net Debt / EBITDA	0.71x	1.04x	1.15x	2.24x	1.78x	1.65x	1.93x	1.76x	1.47x	1.12x
Interest Coverage	9.36x	8.81x	7.92x	8.77x	10.47x	10.21x	11.47x	9.29x	10.00x	11.31x
Total Equity+	1.15B	1.17B	1.31B	1.42B	1.57B	1.85B	1.98B	2.07B	2.32B	2.49B
Equity Growth %	0.04%	0.02%	0.12%	0.08%	0.1%	0.18%	0.07%	0.04%	0.12%	0.07%
Book Value per Share	17.83	18.11	20.31	21.90	23.77	27.77	29.32	31.00	34.70	36.72
Total Shareholders' Equity	1.15B	1.17B	1.31B	1.42B	1.57B	1.85B	1.97B	2.05B	2.31B	2.47B
Common Stock	667K	660K	667K	673K	686K	695K	704K	709K	717K	725K
Retained Earnings	1.19B	1.2B	1.3B	1.37B	1.52B	1.64B	1.79B	1.93B	2.11B	2.37B
Treasury Stock	-270.05M	-250.92M	-346.25M	-318.21M	-381.24M	-361.58M	-421.2M	-503.27M	-539.4M	-595.78M
Accumulated OCI	-262.35M	-319.71M	-253.3M	-310.5M	-341.95M	-281.71M	-316.04M	-341.37M	-308.73M	-429.48M
Minority Interest	295K	292K	310K	315K	336K	396K	15.19M	14.27M	14.47M	14.04M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	323.76M	325.3M	324.73M	313.63M	514.46M	570.15M	363.44M	478.62M	575.24M	643.41M
Operating CF Margin %	0.14%	0.14%	0.13%	0.11%	0.18%	0.19%	0.11%	0.14%	0.16%	0.18%
Operating CF Growth %	0.02%	0%	-0%	-0.03%	0.64%	0.11%	-0.36%	0.32%	0.2%	0.12%
Net Income	199.29M	205.6M	220.03M	194.77M	242.23M	214.09M	243.64M	239.56M	284.18M	374.18M
Depreciation & Amortization	138.89M	154.8M	153.09M	171.75M	194.55M	220.3M	234.85M	233.71M	248.59M	263.78M
Stock-Based Compensation	20.61M	19.82M	18.92M	19.56M	23.89M	34.15M	38.87M	40.94M	41.29M	47.65M
Deferred Taxes	-7.14M	-11.11M	2.24M	-23.35M	8.75M	-8.2M	-14.36M	-12.11M	-19.88M	-21.41M
Other Non-Cash Items	20.59M	15.18M	22.76M	13.38M	16.33M	33.47M	30.13M	21.52M	15.31M	11.47M
Working Capital Changes	-48.49M	-59M	-92.32M	-62.48M	28.71M	76.34M	-169.69M	-45M	5.75M	-32.26M
Change in Receivables	-27.76M	-41.72M	-44.66M	-66.97M	8.81M	13.46M	-123.25M	-27.94M	15.43M	-18.08M
Change in Inventory	-18.93M	-834K	-12.99M	-25.18M	605K	13.72M	-79.96M	-60.35M	-10.64M	21.9M
Change in Payables	39.33M	-12.47M	58.24M	60.58M	10M	65.59M	52.3M	55.1M	14.6M	-23.7M
Cash from Investing+	-176.23M	-300.5M	-224.8M	-735.46M	-336.27M	-451.98M	-457.24M	-295.64M	-324.46M	-396.72M
Capital Expenditures	-149.32M	-131.48M	-156.62M	-211.86M	-247.08M	-252.05M	-307.94M	-315.62M	-318.4M	-294.19M
CapEx % of Revenue	0.06%	0.06%	0.06%	0.08%	0.09%	0.09%	0.1%	0.1%	0.09%	0.08%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	5.86M	3.27M	2.98M	14.32M	4.18M	4.12M	4.05M	21.73M	4.91M	-1.23M
Cash from Financing+	-32.31M	-29.71M	114.79M	-14.87M	-197.13M	-73.72M	-81.52M	-162.1M	-171.55M	-225.34M
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-71.25M	-76.66M	-79.94M	-82.35M	-90.21M	-92.66M	-98.51M	-99.46M	-103.68M	-114.06M
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	71.93M	64.52M	65.65M	88.16M	90.83M	-2.77M	58.19M	24.5M	31.23M	54.81M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	174.44M	193.82M	168.1M	101.77M	267.38M	318.11M	55.51M	163M	256.84M	349.22M
FCF Margin %	0.08%	0.08%	0.07%	0.04%	0.09%	0.11%	0.02%	0.05%	0.07%	0.1%
FCF Growth %	0.13%	0.11%	-0.13%	-0.39%	1.63%	0.19%	-0.83%	1.94%	0.58%	0.36%
FCF per Share	2.70	2.99	2.60	1.57	4.04	4.77	0.82	2.44	3.84	5.16
FCF Conversion (FCF/Net Income)	1.62x	1.58x	1.48x	1.61x	2.12x	2.66x	1.49x	2.00x	2.02x	1.72x
Interest Paid	31.66M	36.27M	38.84M	32.01M	34.42M	33.32M	29.07M	35.51M	39.6M	43.52M
Taxes Paid	79.5M	82.2M	77.35M	96.05M	86.1M	93.58M	94.97M	87.53M	111.99M	89.37M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	17.69%	17.69%	17.7%	14.24%	16.17%	12.51%	12.73%	11.81%	12.96%	15.58%
Return on Invested Capital (ROIC)	16.06%	14.85%	13.73%	9.97%	11.08%	9.51%	8.86%	9.1%	9.42%	11.25%
Gross Margin	35.15%	35.73%	35.03%	34.43%	36.41%	37.09%	35.84%	35.03%	36.23%	37.83%
Net Margin	8.6%	8.82%	8.91%	7.04%	8.47%	7.31%	7.56%	7.2%	8.16%	10.45%
Debt / Equity	0.71x	0.81x	0.96x	0.91x	0.80x	0.66x	0.63x	0.59x	0.51x	0.43x
Interest Coverage	9.36x	8.81x	7.92x	8.77x	10.47x	10.21x	11.47x	9.29x	10.00x	11.31x
FCF Conversion	1.62x	1.58x	1.48x	1.61x	2.12x	2.66x	1.49x	2.00x	2.02x	1.72x
Revenue Growth	-10.8%	0.59%	5.94%	11.97%	3.44%	2.43%	10.17%	2.94%	4.97%	2.74%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Beauty And Home	-	-	-	1.45B	1.38B	1.32B	1.46B	1.46B	-	-
Beauty And Home Growth	-	-	-	-	-4.85%	-4.00%	10.24%	0.39%	-	-
Pharma	-	-	-	955.07M	1.1B	1.23B	1.3B	1.37B	-	-
Pharma Growth	-	-	-	-	15.22%	12.14%	5.18%	5.74%	-	-
Food + Beverage	-	-	-	-	-	407.44M	511.11M	523.64M	-	-
Food + Beverage Growth	-	-	-	-	-	-	25.45%	2.45%	-	-
Food And Beverage	-	-	-	386.69M	418.02M	-	-	-	-	-
Food And Beverage Growth	-	-	-	-	8.10%	-	-	-	-	-
Pumps	991.58M	1.03B	1.12B	-	-	-	-	-	-	-
Pumps Growth	-	3.75%	9.18%	-	-	-	-	-	-	-
Closures Product	558.21M	525.42M	547.2M	-	-	-	-	-	-	-
Closures Product Growth	-	-5.87%	4.15%	-	-	-	-	-	-	-
Valves	306.37M	288.56M	326.82M	-	-	-	-	-	-	-
Valves Growth	-	-5.81%	13.26%	-	-	-	-	-	-	-
Other Product	330.48M	337.44M	322.69M	-	-	-	-	-	-	-
Other Product Growth	-	2.11%	-4.37%	-	-	-	-	-	-	-
Injectables	130.5M	150.78M	149.39M	-	-	-	-	-	-	-
Injectables Growth	-	15.54%	-0.92%	-	-	-	-	-	-	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
UNITED STATES	-	-	-	-	-	965.99M	1.08B	1.1B	1B	1.04B
UNITED STATES Growth	-	-	-	-	-	-	11.99%	1.69%	-9.01%	3.68%
Other Europe	122.55M	120.23M	132.99M	146.7M	149.08M	152.38M	170.52M	167.23M	187.34M	748.3M
Other Europe Growth	-	-1.89%	10.62%	10.31%	1.62%	2.21%	11.91%	-1.93%	12.03%	299.43%
Other Foreign Countries	396.32M	381.72M	400.95M	410.95M	384.5M	359.3M	420.22M	292.12M	331.98M	619.55M
Other Foreign Countries Growth	-	-3.68%	5.04%	2.49%	-6.44%	-6.55%	16.95%	-30.48%	13.64%	86.63%
FRANCE	-	-	-	-	-	854.64M	906.06M	938.64M	1.08B	499.8M
FRANCE Growth	-	-	-	-	-	-	6.02%	3.60%	14.81%	-53.62%
ITALY	-	-	-	-	-	148.64M	161.68M	154.82M	172.22M	180.1M
ITALY Growth	-	-	-	-	-	-	8.77%	-4.24%	11.23%	4.58%
SPAIN	-	-	-	-	-	-	-	-	-	171.78M
SPAIN Growth	-	-	-	-	-	-	-	-	-	-
GERMANY	-	-	-	-	-	448.4M	486.93M	512.71M	564.53M	169.89M
GERMANY Growth	-	-	-	-	-	-	8.59%	5.29%	10.11%	-69.91%
CHINA	-	-	-	-	-	-	-	156.58M	152.61M	155.5M
CHINA Growth	-	-	-	-	-	-	-	-	-2.53%	1.90%
U	633.52M	619.81M	642.16M	726.34M	836.77M	-	-	-	-	-
U Growth	-	-2.16%	3.61%	13.11%	15.20%	-	-	-	-	-
D	326.78M	386.55M	416.8M	474.37M	452.41M	-	-	-	-	-
D Growth	-	18.29%	7.83%	13.81%	-4.63%	-	-	-	-	-
I	125.51M	126.89M	131.52M	144.04M	141.87M	-	-	-	-	-
I Growth	-	1.10%	3.65%	9.52%	-1.51%	-	-	-	-	-
Europe	1.29B	1.33B	1.43B	-	-	-	-	-	-	-
Europe Growth	-	3.27%	7.28%	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

AptarGroup, Inc. (ATR) has a price-to-earnings (P/E) ratio of 22.6x. This is roughly in line with market averages.

Growth & Financials

AptarGroup, Inc. (ATR) reported $3.66B in revenue for fiscal year 2024. This represents a 57% increase from $2.34B in 2011.

AptarGroup, Inc. (ATR) grew revenue by 2.7% over the past year. Growth has been modest.

Yes, AptarGroup, Inc. (ATR) is profitable, generating $419.2M in net income for fiscal year 2024 (10.5% net margin).

Dividend & Returns

Yes, AptarGroup, Inc. (ATR) pays a dividend with a yield of 1.35%. This makes it attractive for income-focused investors.

AptarGroup, Inc. (ATR) has a return on equity (ROE) of 15.6%. This is reasonable for most industries.

AptarGroup, Inc. (ATR) generated $306.4M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...